Product Code: GVR-1-68038-065-1
Next-generation Sequencing Data Analysis Market Growth & Trends:
The global next-generation sequencing data analysis market is expected to reach USD 1.54 billion by 2030, registering a CAGR of 12.69% over the forecast period, according to a new report by Grand View Research, Inc. The growth can be attributed to a significant decline in the cost of NGS installation in clinical diagnosis. Furthermore, the accessibility of genomic and proteomic data is anticipated to create significant growth opportunities. In addition, a reduction in the cost of sequencing is anticipated to boost the adoption rate of NGS, which would further drive the industry. The availability of tools, such as the Targeted Methyl-Seq platform and Agilent's HaloPlex capture system from EpiGentek Group Inc. has aided in the DNA methylation profiles determination in individual genomes. The COVID-19 pandemic has enhanced NGS usage and has created a huge demand.
The NGS tools can generate a significant amount of data for scientists to analyze and study pathogenesis. Researchers from industry, academia, and government have used data analysis technology to help in understanding the characteristics, phylogenetics, and processes of SARS-CoV2. NGS technologies have helped to unveil biological information that has not been studied yet using conventional technologies. For instance, NGS has helped study genomic patterns associated with various biological processes and epigenomics. However, issues related to accessing storage management, and analysis of data are anticipated to offer huge R&D prospects, thus, driving the industry growth. Researchers that use high-throughput sequencers demand software systems, such as Laboratory Information Management Systems (LIMS) to archive and handle sequencing information.
Furthermore, the introduction of workflow management system solutions, such as Galaxy and Chipster, drives demand for technological advancements in data storage and management. Demand for technologically advanced infrastructure to monitor the flow of data analysis process from data generation to preliminary analysis to higher-level analysis has increased. Moreover, NGS data analysis tools are being constantly upgraded for obtaining effective results and higher utility. For instance, in December 2021, Bionano Genomics launched BioDiscovery's NxClinical Software Version 6.1 for genome analysis. The version enables enhanced visualization and interpretation of NGS data for cancer and genetic disease domains. Such developments are anticipated to drive the industry over the forecast period.
Next-generation Sequencing Data Analysis Market Report Highlights:
- The services product segment dominated the industry in 2021. NGS has several advantages, in terms of speed and affordability, and many research institutes are unable to adopt it due to a lack of skilled professionals and sufficient computational infrastructure
- The tertiary analysis workflow segment captured the major revenue share in 2021 as it accounts for the complex and important step of NGS, which is linked with the interpretation of the results
- The in-house mode segment dominated the market in 2021 and is anticipated to remain dominant in the coming years. However, the outsourced mode segment is anticipated to witness the fastest growth rate from 2022 to 2030 owing to time and cost advantages
- The short-read sequencing segment held the maximum share in 2021 due to the high adoption of short-read sequencing techniques and their cost-effective nature & ability to work with DNA fragments and the availability of several tools & algorithms
- The academic research end-use segment dominated the market in 2021. A reduction in the NGS technology cost has fueled the NGS software platforms usage by several research centers & academic institutions for their research that require data interpretation
- North America captured the highest revenue share in 2021 owing to the presence of well-developed information technology companies, favorable reimbursement network, and high government funding and high public & private expenditures in the biotechnology sector
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Research Assumptions
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.4 Information or Data Analysis
- 1.5 Market Formulation & Validation
- 1.6 Market Model
- 1.7 Global Market: CAGR Calculation
- 1.8 Objectives
- 1.8.1 Objective 1
- 1.8.2 Objective 2
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
- 2.4 Market Summary
Chapter 3 Market Variables, Trends, and Scope
- 3.1 Market Trends and Outlook
- 3.2 Market Segmentation and Scope
- 3.3 Market Dynamics
- 3.3.1 Market Driver Analysis
- 3.3.1.1 Demand For Efficient Algorithms And Tools For Analysis Of Large Amount Of Data Generated By Sequencers
- 3.3.1.2 Introduction Of Technological Advancements In Cloud Computing And Data Integration
- 3.3.1.3 Increasing Penetration Of The NGS Technology In Personalized Medicine And Precision Diagnosis
- 3.3.1.4 Rising Academic Research Based On NGS Protocols
- 3.3.2 Market Restraint Analysis
- 3.3.2.1 Challenges In Sequence Compression And Data Storage
- 3.3.2.2 Selection Of Appropriate Algorithms And Parallelizing Scientific Workflows
- 3.3.2.3 Budget And Time Constraints
- 3.4 Next Generation Sequencing Data Analysis Company Heat Map Analysis, 2021
- 3.4.1 Company Size
- 3.4.2 Geographical Presence
- 3.4.3 Product Portfolio
- 3.4.4 Strategic Initiatives
- 3.5 Business Environment Analysis
- 3.5.1 SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
- 3.5.2 Porter's Five Forces Analysis
- 3.6 Penetration And Growth Prospect Mapping For Application, 2021 (USD Million)
- 3.7 Covid-19 Impact Analysis
- 3.7.1 Challenge Analysis
- 3.7.2 Opportunity Analysis
- 3.7.3 Key Developments And Activities
- 3.8 Pricing Analysis
- 3.8.1 Icredit Charges For Illumina's Portfolio
- 3.8.2 Other Pricing Strategies
Chapter 4 Market Categorization: Read Length Estimates and Trend Analysis
- 4.1 NGS Data Analysis Market: Read Length Movement Analysis
- 4.2 Short Read Sequencing
- 4.2.1 Global Short Read Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
- 4.3 Long Read Sequencing
- 4.3.1 Global Long Read Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
- 4.4 Very Long Read Sequencing
- 4.4.1 Global Very Long Read Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
Chapter 5 Market Categorization: Product Estimates and Trend Analysis
- 5.1 NGS Data Analysis Market: Product Movement Analysis
- 5.2 NGS Data Analysis Services
- 5.2.1 NGS Data Analysis Services Market, 2018 - 2030 (USD Million)
- 5.3 NGS Commercial Software
- 5.3.1 NGS Commercial Software Market, 2018 - 2030 (USD Million)
- 5.3.2 Platform OS/UI
- 5.3.2.1 NGS Platform Os/Ui Market, 2018 - 2030 (USD Million)
- 5.3.3 Analytical Software
- 5.3.3.1 NGS Analytical Software market, 2018 - 2030 (USD Million)
- 5.3.3.2 Alignment Tools & Software
- 5.3.3.2.1 NGS Alignment Tools & Software market, 2018 - 2030 (USD million)
- 5.3.3.2.2 DNA sequencing Alignment
- 5.3.3.2.2.1 Global DNA sequencing alignment market, 2018 - 2030 (USD Million)
- 5.3.3.2.3 RNA sequence alignment
- 5.3.3.2.3.1 Global RNA sequence alignment market, 2018 - 2030 (USD Million)
- 5.3.3.2.4 Protein sequence alignment
- 5.3.3.2.4.1 Global protein sequence alignment market, 2018 - 2030 (USD Million)
- 5.3.3.3 QC/Pre-processing tools
- 5.3.3.3.1 Global NGS QC/Pre-processing tools market, 2018 - 2030 (USD Million)
- 5.3.3.4 others
- 5.3.3.4.1 Global others NGS analytical software market, 2018 - 2030 (USD Million)
Chapter 6 Market Categorization: Workflow Business Analysis
- 6.1 NGS Data Analysis Market: Workflow Movement Analysis
- 6.2 Primary Data NGS Analysis
- 6.2.1 Global NGS Primary Data Analysis Market, 2018 - 2030 (USD Million)
- 6.3 Secondary Data Analysis
- 6.3.1 Global NGS Secondary Data Analysis Market, 2018 - 2030 (USD Million)
- 6.3.2 Read Mapping
- 6.3.2.1 Global NGS Read Mapping Market, 2018 - 2030 (USD Million)
- 6.3.3 Variant Alignment & Variant Calling
- 6.3.3.1 Global NGS Variant Alignment & Variant Calling Data Analysis Market, 2018 - 2030 (USD Million)
- 6.4 Tertiary Data Analysis
- 6.4.1 Global NGS Tertiary Data Analysis Market, 2018 - 2030 (USD Million)
- 6.4.2 Variant Annotation
- 6.4.2.1 Global NGS Variant Annotation Data Analysis Market, 2018 - 2030 (USD Million)
- 6.4.3 Application-Specific Data Analysis
- 6.4.3.1 Global NGS Application specific data analysis market, 2018 - 2030 (USD Million)
- 6.4.3.2 Targeted sequencing/ gene panel
- 6.4.3.2.1 Global targeted sequencing/ gene panel data analysis market, 2018 - 2030 (USD Million)
- 6.4.3.3 Exome sequencing
- 6.4.3.3.1 Global exome sequencing data analysis market, 2018 - 2030 (USD Million)
- 6.4.3.4 RNA sequencing
- 6.4.3.4.1 Global RNA sequencing data analysis market, 2018 - 2030 (USD Million)
- 6.4.3.5 Whole Genome Sequencing
- 6.4.3.5.1 Global whole genome sequencing data analysis market, 2018 - 2030 (USD Million)
- 6.4.3.6 ChIP-sequencing
- 6.4.3.6.1 Global ChIP-sequencing data analysis market, 2018 - 2030 (USD Million)
- 6.4.3.7 others
- 6.4.3.7.1 Global other application-specific data analysis market, 2018 - 2030 (USD Million)
Chapter 7 Market Categorization: Mode Estimates and Trend Analysis
- 7.1 NGS Data Analysis Market: Mode Movement Analysis
- 7.2 In-House Data Analysis
- 7.2.1 In-House Data Analysis Market, 2018 - 2030 (USD Million)
- 7.3 Outsourced Data Analysis
- 7.3.1 Outsourced Data Analysis Market, 2018 - 2030 (USD Million)
Chapter 8 Market Categorization: End-use Business Analysis
- 8.1 NGS Data Analysis Market: End-use Movement Analysis
- 8.2 Academic Research
- 8.2.1 Global NGS Data Analysis Market For Academic Research, 2018 - 2030 (USD Million)
- 8.3 Clinical Research
- 8.3.1 Global NGS Data Analysis Market For Clinical Research, 2018 - 2030 (USD Million)
- 8.4 Hospitals & Clinics
- 8.4.1 Global NGS Data Analysis Market For Hospitals & Clinics, 2018 - 2030 (USD Million)
- 8.5 Pharmaceutical & Biotech Entities
- 8.5.1 Global NGS Data Analysis Market For Pharmaceutical & Biotech Entities, 2018 - 2030 (USD Million)
- 8.6 Other Users
- 8.6.1 Global NGS Data Analysis Market For Other Users, 2018 - 2030 (USD Million)
Chapter 9 Region Business Analysis
- 9.1 NGS Data Analysis Market: Regional Movement Analysis, 2021 & 2030
- 9.2 North America
- 9.2.1 North America NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.2.2 U.S. NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.2.3 Canada NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.3 Europe
- 9.3.1 Europe NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.3.2 Germany NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.3.3 U.K. NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.3.4 France NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.3.5 Italy NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.3.6 Spain NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.4 Asia-Pacific
- 9.4.1 Asia Pacific NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.4.2 Japan NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.4.3 China NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.4.4 India NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.4.5 South Korea NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.4.6 Australia NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.5 Latin America
- 9.5.1 Latin America
- 9.5.2 Latin America NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.5.3 Brazil NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.5.4 Mexico NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.6 Middle East And Africa (MEA)
- 9.6.1 Mea NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.6.2 South Africa NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.6.3 Saudi Arabia NGS Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 10 Company Profile
- 10.1 Strategy Framework
- 10.2 Market Participation Categorization
- 10.3 Company Profiles
- 10.3.1 QIAGEN N.V.
- 10.3.1.1 Company Overview
- 10.3.1.2 Clc Bio
- 10.3.1.2.1 Company Overview
- 10.3.1.3 Financial Performance
- 10.3.1.4 Product Benchmarking
- 10.3.1.5 Strategic Initiatives
- 10.3.2 ILLUMINA, INC.
- 10.3.2.1 Company Overview
- 10.3.2.2 Edico Genome
- 10.3.2.2.1 Company Overview
- 10.3.2.3 Financial Performance
- 10.3.2.4 Product Benchmarking
- 10.3.2.5 Strategic Initiatives
- 10.3.3 F. HOFFMANN-LA ROCHE LTD.
- 10.3.3.1 Company Overview
- 10.3.3.2 Financial Performance
- 10.3.3.3 Product Benchmarking
- 10.3.3.4 Strategic Initiatives
- 10.3.4 THERMO FISHER SCIENTIFIC, INC.
- 10.3.4.1 Company Overview
- 10.3.4.2 Life Technologies Corp.
- 10.3.4.2.1 Company Overview
- 10.3.4.3 Financial Performance
- 10.3.4.4 Product Benchmarking
- 10.3.4.5 Strategic Initiatives
- 10.3.5 AGILENT TECHNOLOGIES, INC.
- 10.3.5.1 Company Overview
- 10.3.5.2 Financial Performance
- 10.3.5.3 Product Benchmarking
- 10.3.5.4 Strategic Initiatives
- 10.3.6 BIO-RAD LABORATORIES, INC.
- 10.3.6.1 Company Overview
- 10.3.6.2 Gnubio
- 10.3.6.2.1 Company Overview
- 10.3.6.3 Financial Performance
- 10.3.6.4 Product Benchmarking
- 10.3.6.5 Strategic Initiatives
- 10.3.7 PIERIANDX
- 10.3.7.1 Company Overview
- 10.3.7.2 Tute Genomics
- 10.3.7.2.1 Company Overview
- 10.3.7.2.2 Knome, Inc.
- 10.3.7.2.2.1 Company Overview
- 10.3.7.3 Financial Performance
- 10.3.7.4 Product Benchmarking
- 10.3.7.5 Strategic Initiatives
- 10.3.8 PRECIGEN BIOINFORMATICS GERMANY GMBH, DBA GENOMATIX
- 10.3.8.1 Company Overview
- 10.3.8.2 Financial Performance
- 10.3.8.3 Product Benchmarking
- 10.3.8.4 Strategic Initiatives
- 10.3.9 PARTEK INCORPORATED
- 10.3.9.1 Company Overview
- 10.3.9.2 Financial Performance
- 10.3.9.3 Product Benchmarking
- 10.3.9.4 Strategic Initiatives
- 10.3.10 EUROFINS SCIENTIFIC
- 10.3.10.1 Company Overview
- 10.3.10.2 Eurofins Gatc Biotech Gmbh
- 10.3.10.2.1 Company Overview
- 10.3.10.3 Financial Performance
- 10.3.10.3.1 Financial Performance: Eurofins Gatc Biotech Gmbh
- 10.3.10.4 Product Benchmarking
- 10.3.10.5 Strategic Initiatives
- 10.3.11 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- 10.3.11.1 Company Overview
- 10.3.11.2 Financial Performance
- 10.3.11.3 Product Benchmarking
- 10.3.11.4 Strategic Initiatives
- 10.3.12 DNASTAR, INC.
- 10.3.12.1 Company Overview
- 10.3.12.2 Financial Performance
- 10.3.12.3 Product Benchmarking
- 10.3.12.4 Strategic Initiatives
- 10.3.13 CONGENICA LTD.
- 10.3.13.1 Company Overview
- 10.3.13.2 Financial Performance
- 10.3.13.3 Product Benchmarking
- 10.3.13.4 Strategic Initiatives
- 10.3.14 FABRIC GENOMICS, INC.
- 10.3.14.1 Company Overview
- 10.3.14.2 Financial Performance
- 10.3.14.3 Product Benchmarking
- 10.3.14.4 Strategic Initiatives
- 10.3.15 GENUITY SCIENCE
- 10.3.15.1 Company Overview
- 10.3.15.2 Financial Performance
- 10.3.15.3 Product Benchmarking
- 10.3.15.4 Strategic Initiatives
- 10.3.16 DNANEXUS, INC.
- 10.3.16.1 Company Overview
- 10.3.16.2 Financial Performance
- 10.3.16.3 Product Benchmarking
- 10.3.16.4 Strategic Initiatives
- 10.3.17 SCIGENOM LABS PVT. LTD.
- 10.3.17.1 Company Overview
- 10.3.17.2 Product Benchmarking
- 10.3.17.3 Strategic Initiatives
- 10.3.18 GOLDEN HELIX, INC.
- 10.3.18.1 Company Overview
- 10.3.18.2 Financial Performance
- 10.3.18.3 Product Benchmarking
- 10.3.18.4 Strategic Initiatives
- 10.3.19 VERILY LIFE SCIENCE
- 10.3.19.1 Company Overview
- 10.3.19.2 Financial Performance
- 10.3.19.3 Product Benchmarking
- 10.3.19.4 Strategic Initiatives